Bennett adds over 30 years of experience in life sciences sector across the West Coast
Palo Alto, Calif. – Aug. 1, 2022 – CBRE announced the hire of James Bennett as Vice Chairman in Palo Alto. Mr. Bennett will join CBRE’s life sciences practice in the San Francisco Bay Area, bringing over 30 years of experience in tenant and landlord representation, investment sales, asset management, development and valuation.
Previously, Mr. Bennett held a senior leadership role in Kidder Matthews’ life sciences group where he was involved in major tenant and landlord assignments throughout the West Coast, including the San Francisco Bay Area and San Diego.
Mr. Bennett has represented a range of tenants including Big Pharma, large and mid-cap publicly traded biotech companies and early-stage venture backed firms. He has also represented a variety of investors and developers, ranging from institutional REITs and multi-national investment firms to local building owners.
“James is well-respected throughout the industry and adds to the caliber of our talented life sciences team in the Bay Area. His tremendous experience and expertise have been invaluable to clients, which is illustrative of his leadership in the sector,” said Reed Payne, Senior Managing Director of CBRE’s Palo Alto office.
About CBRE Group, Inc.
CBRE Group, Inc. (NYSE:CBRE), a Fortune 500 and S&P 500 company headquartered in Dallas, is the world’s largest commercial real estate services and investment firm (based on 2021 revenue). The company has more than 105,000 employees (excluding Turner & Townsend employees) serving clients in more than 100 countries. CBRE serves a diverse range of clients with an integrated suite of services, including facilities, transaction and project management; property management; investment management; appraisal and valuation; property leasing; strategic consulting; property sales; mortgage services and development services. Please visit our website at www.cbre.com.
The full content of this article is only available to paid subscribers. If you are an active subscriber, please log in. To subscribe, please click here: SUBSCRIBE
